Project Grant R01MH138225

Award Date 9/6/24
Completion Date 3/21/25
Dollars Obligated $2.1M
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,155,836 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Miami. The funding will support a 5-year, randomized hybrid implementation/effectiveness trial titled "TEST-TO-PREP: A Randomized Hybrid Implementation/Efficacy Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information." The study aims to evaluate the...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a $1,554,880 initiative titled "Integrating PrEP Decision-Making into Contraceptive Counseling in Family Planning Clinics". The award aims to expand and enhance an existing PrEP decision aid, and integrate its delivery into sexual and reproductive health settings during contraceptive counseling visits, to increase PrEP access and uptake...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $911,400 Project Grant to Emory University to establish the PREMISE (PrEP Epidemiology, Modeling, and Surveillance) system. The goal is to use national PrEP prescription data, legal/policy coding, and natural experimental designs to inform the U.S. HIV epidemic response and understand which programs and policies are effective at facilitating...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...
The National Institute of Mental Health (NIMH) awarded a $252,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Albert Einstein College of Medicine in Bronx, NY. The grant, titled "Participatory System Dynamics to Enhance PrEP Access for Black and Latinx Sexual Minority Men in Bronx, NY," aims to identify and pilot test strategies to improve access to and use of pre-exposure prophylaxis (PrEP) among Black and Latinx sexual minority men in the Bronx, a population...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,589,319 to Yale University to leverage social determinants data and spatial data science to reduce HIV incidence across the United States. The key products and services to be delivered under this grant include: Creating transportation-based measures of pre-exposure prophylaxis (PrEP) accessibility at the county and...
This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop, pilot, and evaluate a multilevel intervention that combines a refined media campaign and peer-based strategy to promote pre-exposure prophylaxis (PrEP) uptake among young Latino sexual minority men. The $186,840 award, effective from September 1, 2024, to August 31, 2028, will be administered by the University of Chicago. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,576,238 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Miami. The grant will fund a project titled "Leveraging a Strategic Alliance of Community-Based Implementers and Researchers to Characterize, Protocolize, and Scale Up Local Implementation Strategies for Ending the HIV Epidemic Among Latino MSM." The project aims to characterize, assess, and...

This Project Grant award, totaling $2,127,639, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855).

The grant supports a research project to develop a multi-level integrated strategy that combines two evidence-based interventions - "Many Men, Many Voices" (3MV) and "Client-Centered Care Coordination" (C4) - to optimize PrEP adherence and accelerate implementation at scale among Black men who have sex with men (MSM). The goal is to address interpersonal and structural stigmas that create barriers to PrEP access and adherence in this population. The project will be implemented by Yale University in collaboration with a sub-awardee, the Research Foundation for the State University of New York. Key objectives include determining the efficacy of the integrated 3MV+C4 approach, identifying the optimal dose of C4, and characterizing implementation determinants to support scale-up. The award commenced on September 6, 2024 and is scheduled for completion on March 21, 2025.

Generated 8/5/25, 4:53 AM